Cellularis Biomodels is a deep-tech company that provides state-of-the-art 3D of human disease for screening candidate therapies in the preclinical phase.
Cellularis' leverages on deep expertise in bioengineering, cell-technologies, 3D biofabrication, and biochemistry, providing living screening platforms and expert advice for preclinical drug discovery and development pipelines.
Our proprietary bioengineering technologies enable the production of physiomimetic 3D disease models that recapitulate key tumor-stroma hallmarks, bioarchitecture and anatomic scale in an in vitro setting.
The company development pipeline includes 3D in vitro tumor-stroma models of Pancreatic, Breast, Prostate and Lung cancer combining cells and extracellular matrix biomaterials to mimic the tumor microenvironment.
Cellularis Biomodels aims to advance the preclinical screening toolbox while contributing to reducing animal experimentation for therapeutics validation.
Company Details
- Employees
- 13
- Founded
- 2021
- Address
- Creative Science Park Aveiro Region Via Do Conhecimento, Edifício Central 3830-352 Ílhavo, Portugal, Aveiro,portugal
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cellularisbiomodels.com/
- Keywords
- in bioengineering.
- HQ
- Aveiro
Cellularis Biomodels Questions
Cellularis Biomodels's website is https://cellularisbiomodels.com/
Cellularis Biomodels's LinkedIn profile is https://pt.linkedin.com/company/cellularis-biomodels
Cellularis Biomodels has
13 employees.
View email and phone details for 13
employees at Cellularis Biomodels.
Cellularis Biomodels's industry is
Biotechnology Research
Cellularis Biomodels's top competitors are
Cell4food,
Brinova Biochemistry,
Bluepharma,
Vetherapy® - Veterinary Regenerative Medicine,
Ciceco - Aveiro Institute Of Materials,
Corium Biotech,
Tech4med,
Stemmatters,
Byspectra,
Metatissue.
Cellularis Biomodels's categories are Biotechnology Research
Cellularis Biomodels's founding year is 2021
